4,4',6-trimethylangelicin has been researched along with interleukin-8 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bezzerri, V; Bianchi, N; Borgatti, M; Cabrini, G; Casavola, V; Dall'Acqua, F; Fabbri, E; Favia, M; Finotti, A; Gambari, R; Guerra, L; Lampronti, I; Mancini, I; Nicolis, E; Piccagli, L; Salvador, A; Tamanini, A; Vedaldi, D | 1 |
1 other study(ies) available for 4,4',6-trimethylangelicin and interleukin-8
Article | Year |
---|---|
Trimethylangelicin reduces IL-8 transcription and potentiates CFTR function.
Topics: Bronchi; Cell Line; Chlorides; Cystic Fibrosis Transmembrane Conductance Regulator; Dose-Response Relationship, Drug; Epithelial Cells; Furocoumarins; Gene Expression Regulation; Humans; Interleukin-8; NF-kappa B; Phosphoproteins; Phosphorylation; Promoter Regions, Genetic; Protein Binding; Pseudomonas aeruginosa; RNA, Messenger; Transcription, Genetic; Trioxsalen | 2011 |